Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer

Clinical trial NCT06138028 · RECRUITING

Trial details

NCT number: NCT06138028
Sponsor: Qingdao Central Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Metastatic Esophageal Squamous Cell Carcinoma

Start date: 2023-09-20
Primary completion: 2025-10-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.